Kevin M. Brennan

SVP, FINANCE AND ACCOUNTING, Xilio Therapeutics, Inc.

Companies

Xilio Therapeutics, Inc.SVP, FINANCE AND ACCOUNTING Apr 3, 2023 to now¹

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Xilio Therapeutics, Inc. XLO6,371 shares²$53.1K at $8.33Jan 2, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

Jan 2, 2026Sold 1,826 shares at $0.64 of Xilio Therapeutics, Inc.²
Jan 1, 2026Exercised options 5,000 shares of Xilio Therapeutics, Inc.²
Jan 2, 2025Sold 1,803 shares at $0.98 of Xilio Therapeutics, Inc.³
Jan 1, 2025Exercised options 5,000 shares of Xilio Therapeutics, Inc.³

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARXilio Therapeutics, Inc., SVP, FINANCE AND ACCOUNTING
2
SEC EDGARXilio Therapeutics, Inc. shares after the filing of Jan 2, 2026
3
SEC EDGARForm 4 filed Jan 3, 2025